Biotech

All Articles

Takeda touches new mind people oncology business-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant leadership hirings, shootings and...

Vertex, beaten through AATD again, goes down 2 possessions on throw away pile

.Vertex's effort to treat an unusual genetic condition has actually reached yet another misfortune. ...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter profits document wasn't except big updates. The provider welcomed a tr...

Galapagos stops briefly CAR-T cell treatment trial over Parkinsonism situation

.Galapagos has stopped briefly registration in a trial of a BCMA-directed CAR-T cell treatment, push...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After more than 30 years, genetics treatment pioneer James Wilson M.D., Ph.D., is actually leaving ...

3 biotechs make an effort to trump the summertime heat energy by losing team

.As biotechs attempt to switch a new webpage in August, at the very least three companies have shed ...

venBio raises $528M for fifth lifestyle scientific researches VC fund

.Pro equity capital agency venBio has lifted one more half a billion dollars to buy biotechs servici...

Otsuka pays $800M for Jnana and its clinical-stage PKU drug

.Otsuka Drug has actually grabbed Boston-based Jnana Therapeutics for $800 thousand so the Japanese ...

FibroGen lays off 75% of US staff as asset fails 2 additional tests

.FibroGen is significantly reorganizing its own organization, laying off 75% of its USA staff as wel...

Tracon winds down full weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has chosen to unwind operations weeks after an injectable immune checkpoint ...